Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy

Diabetes Therapy - United States
doi 10.1007/s13300-019-0635-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pdb64 - Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effect of Switching Basal Insulin Regimen to Degludec on Quality of Life in Japanese Patients With Type 1 and Type 2 Diabetes Mellitus

Journal of Pharmaceutical Health Care and Sciences
2015English

Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2012English

A European, Multicentre, Retrospective, Non-Interventional Study (EU-TREAT) of the Effectiveness of Insulin Degludec After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch With an Insulin Pen

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2019English

The Relationships Between Glucose Variability and Renal Function in Type 2 Diabetes Patients on Basal-Bolus Insulin Therapy

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Diabetes Management and Healthcare Resource Use When Intensifying From Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Pdb61 - Cost-Effectiveness Analysis of Human or Analogue Basal Insulin-Supported Oral Therapy in Type 2 Diabetes in Hungary

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy